Transplantation Proceedings 2010-01-01

The Effects of Gabexate Mesilate on the Microsurgical Reconstruction of the Hepatic Artery in Living Donor Liver Transplantation

S. Miyagi, Y. Enomoto, S. Sekiguchi, N. Kawagishi, S. Satomi, S. Miyagi, Y. Enomoto, S. Sekiguchi, N. Kawagishi, S. Satomi

Index: Transplant. Proc. 42(10) , 4158-60, (2010)

Full Text: HTML

Abstract

Objectives Microsurgical reconstruction of hepatic artery is essential but require challenging techniques especially for living donor liver transplantation (LDLT), because the recipient artery is short, located deep, and usable vessel grafts are limited. Furthermore, hepatic artery thrombosis (HAT) can be a lethal complication. Therefore, we began the systemic administration of gabexate mesilate, a strong serine protease inhibitor. It has often been effective to treat disseminated intravascular coagulation. The purpose of this study was to examine the effects of gabexate mesilate on the microvascular reconstruction.

Related Compounds

  • Gabexate mesylate

Related Articles:

Involvement of proteinase activated receptor-2 in the vascular response to sphingosine 1-phosphate.

2014-04-01

[Clin. Sci. 126(8) , 545-56, (2014)]

Role of TRPV1 in nociception and edema induced by monosodium urate crystals in rats.

2011-08-01

[Pain 152(8) , 1777-88, (2011)]

Neonatal amygdala lesions advance pubertal timing in female rhesus macaques.

2015-01-01

[Psychoneuroendocrinology 51 , 307-17, (2014)]

The short term satiety peptide cholecystokinin reduces meal size and prolongs intermeal interval.

2011-06-01

[Peptides 32(6) , 1289-95, (2011)]

Effect of a serine protease inhibitor on the progression of chronic renal failure.

2012-10-15

[Am. J. Physiol. Renal Physiol. 303(8) , F1126-35, (2012)]

More Articles...